Viewing Study NCT02733250


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-02-20 @ 6:34 PM
Study NCT ID: NCT02733250
Status: COMPLETED
Last Update Posted: 2021-02-16
First Post: 2016-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None Pembrolizumab View
None Nab-paclitaxel View